BeOne Medicines reported revenue of $1705.07M and net income of $237.01M for the quarter ended Jun 2026, up 29.6% year over year. This income statement covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 206.44M | 213.98M | 306.63M | 341.57M | 387.63M | 380.10M | 447.80M | 595.26M | 781.31M | 634.41M | 751.65M | 929.17M | 1,001.60M | 1,127.82M | 1,117.28M | 1,315.30M | 1,412.28M | 1,498.17M | 1,513.44M | 1,705.07M | ||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 47.41M | 48.55M | 65.24M | 71.17M | 76.54M | 73.52M | 81.79M | 95.99M | 96.31M | 105.83M | 124.94M | 138.13M | 170.46M | 160.56M | 165.00M | 164.61M | 196.51M | 142.42M | 167.22M | 174.53M | ||||||||||||||||||||||||||
| Gross Profit | 159.03M | 165.43M | 241.39M | 270.40M | 311.08M | 306.57M | 366.01M | 499.27M | 685.00M | 528.58M | 626.72M | 791.03M | 831.14M | 967.26M | 952.28M | 1,150.69M | 1,215.77M | 1,355.75M | 1,346.22M | 1,530.54M | ||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Amortization - Intangibles | 0.40M | 0.82M | 1.02M | 1.00M | 0.99M | 0.97M | 0.99M | 1.03M | 2.27M | 2.96M | 1.18M | 1.18M | ||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 351.94M | 430.49M | 389.92M | 378.21M | 426.36M | 446.02M | 408.58M | 422.76M | 453.26M | 493.99M | 460.64M | 454.47M | 496.18M | 542.01M | 481.89M | 524.90M | 523.66M | 615.42M | 541.22M | 612.28M | ||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 269.23M | 306.50M | 294.57M | 331.40M | 322.89M | 329.74M | 328.50M | 395.03M | 365.71M | 418.38M | 427.43M | 443.73M | 455.22M | 504.68M | 459.29M | 537.91M | 529.00M | 555.29M | 555.10M | 593.21M | ||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 47.60M | -116.17M | 65.42M | 71.36M | 76.73M | -213.52M | 0.19M | 0.19M | ||||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 668.76M | 620.81M | 749.91M | 780.97M | 825.99M | 562.24M | 737.27M | 817.99M | 818.97M | 912.37M | 888.07M | 898.20M | 951.40M | 1,046.69M | 941.17M | 1,062.81M | 1,052.66M | 1,170.71M | 1,096.32M | 1,205.49M | ||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -462.32M | -571.74M | -443.29M | -439.40M | -438.36M | -468.62M | -371.26M | -318.71M | -133.97M | -383.80M | -261.35M | -107.16M | -120.27M | -79.42M | 11.10M | 87.89M | 163.11M | 185.03M | 249.90M | 325.05M | ||||||||||||||||||||||||||
| EBIT | -462.32M | -571.74M | -443.29M | -439.40M | -438.36M | -468.62M | -371.26M | -318.71M | -133.97M | -383.80M | -261.35M | -107.16M | -120.27M | -79.42M | 11.10M | 87.89M | 163.11M | 185.03M | 249.90M | 325.05M | ||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 7.00M | 8.00M | 32.89M | 39.74M | ||||||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 26.65M | 20.64M | 16.16M | 13.22M | 10.64M | 29.61M | 12.85M | 11.49M | 3.03M | 58.13M | 27.66M | 27.90M | ||||||||||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 31.48M | -10.58M | 11.97M | -129.62M | -125.64M | 19.44M | 18.30M | -63.82M | 336.66M | 16.75M | 1.76M | -11.98M | 11.32M | -13.73M | 3.95M | 8.17M | -18.98M | -35.69M | 14.54M | -0.75M | ||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||||
| EBT | -433.08M | -586.80M | -421.25M | -557.59M | -551.24M | -430.96M | -336.94M | -367.46M | 229.34M | -350.77M | -243.43M | -105.92M | -98.30M | -85.35M | 20.90M | 99.55M | 147.16M | 149.24M | 259.21M | 312.46M | ||||||||||||||||||||||||||
| Tax ProvisionsTaxes | 5.04M | 3.87M | 13.95M | 8.14M | 6.32M | 14.37M | 11.49M | 13.67M | 13.93M | 16.78M | 7.72M | 14.48M | 23.05M | 66.53M | 19.63M | 5.23M | 22.32M | 82.74M | 31.86M | 75.45M | ||||||||||||||||||||||||||
| Profit After TaxPAT | -438.11M | -590.68M | -435.20M | -565.73M | -557.56M | -445.33M | -348.43M | -381.14M | 215.41M | -367.55M | -251.15M | -120.41M | -121.35M | -151.88M | 1.27M | 94.32M | 124.84M | 66.50M | 227.36M | 237.01M | ||||||||||||||||||||||||||
| Equity Income | 23.76M | -9.53M | -16.97M | -5.91M | -2.95M | -5.58M | -0.17M | -2.48M | -2.67M | -3.95M | ||||||||||||||||||||||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | ||||||||||||||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -438.11M | -590.68M | -435.20M | -565.73M | -557.56M | -445.33M | -348.43M | -381.14M | 215.41M | -367.55M | -251.15M | -120.41M | -121.35M | -151.88M | 1.27M | 94.32M | 124.84M | 66.50M | 227.36M | 237.01M | ||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -438.11M | -590.68M | -435.20M | -565.73M | -557.56M | -445.33M | -348.43M | -381.14M | 215.41M | -367.55M | -251.15M | -120.41M | -121.35M | -151.88M | 1.27M | 94.32M | 124.84M | 66.50M | 227.36M | 237.01M | ||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -438.11M | -590.68M | -435.20M | -565.73M | -557.56M | -445.33M | -348.43M | -381.14M | 215.41M | -367.55M | -251.15M | -120.41M | -121.35M | -151.88M | 1.27M | 94.32M | 124.84M | 66.50M | 227.36M | 237.01M | ||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -438.11M | -590.68M | -435.20M | -565.73M | -557.56M | -445.33M | -348.43M | -381.14M | 215.41M | -367.55M | -251.15M | -120.41M | -121.35M | -151.88M | 1.27M | 94.32M | 124.84M | 66.50M | 227.36M | 237.01M | ||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -4.72 | -6.37 | -4.25 | -5.50 | -5.39 | -4.32 | -3.34 | -3.64 | 2.06 | -3.52 | -2.41 | -1.15 | -1.15 | -1.44 | 0.01 | 0.87 | 1.13 | 0.61 | 2.05 | 2.12 | ||||||||||||||||||||||||||
| EPS (Diluted) | -4.72 | -6.37 | -4.25 | -5.50 | -5.39 | -4.32 | -3.34 | -3.64 | 2.01 | -3.52 | -2.41 | -1.15 | -1.15 | -1.44 | 0.01 | 0.84 | 1.09 | 0.59 | 1.96 | 2.05 | ||||||||||||||||||||||||||
| Shares Outstanding | 92.77M | 92.79M | 102.46M | 102.80M | 103.48M | 103.13M | 104.17M | 104.63M | 104.67M | 104.39M | 104.27M | 104.70M | 105.90M | 105.29M | 106.93M | 108.32M | 110.22M | 109.06M | 110.96M | 111.58M | ||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 92.77M | 92.79M | 102.46M | 102.80M | 103.48M | 103.13M | 104.17M | 104.63M | 106.95M | 104.39M | 104.27M | 104.70M | 105.90M | 105.29M | 111.17M | 112.56M | 114.52M | 113.45M | 115.77M | 115.80M | ||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 93.33M | 102.68M | 102.68M | 103.82M | 103.82M | 104.32M | 104.82M | 105.87M | 104.08M | 104.58M | 104.58M | 106.08M | 106.62M | 106.72M | 107.94M | 109.86M | 110.62M | 110.85M | 111.11M | 113.02M | ||||||||||||||||||||||||||
| EBITDA | -462.32M | -571.74M | -443.29M | -439.40M | -438.36M | -468.62M | -371.26M | -318.71M | -133.97M | -383.80M | -261.35M | -107.16M | -120.27M | -79.42M | 11.10M | 87.89M | 163.11M | 185.03M | 249.90M | 325.05M | ||||||||||||||||||||||||||
| Interest ExpensesInt Expense | 7.00M | 8.00M | 32.89M | 39.74M | ||||||||||||||||||||||||||||||||||||||||||
| Tax Rate | -1.16% | -0.66% | -3.31% | -1.46% | -1.15% | -3.33% | -3.41% | -3.72% | 6.07% | -4.78% | -3.17% | -13.68% | -23.44% | -77.95% | 93.92% | 5.25% | 15.17% | 55.44% | 12.29% | 24.15% |